| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/15/2004 | US20040010124 CD16A binding proteins and use for the treatment of immune disorders |
| 01/15/2004 | US20040009579 Using microorganisms with restricted colonial and/or extensive hyphal branching phenotypes as bioreactors for expression of heterologous polypeptides |
| 01/15/2004 | US20040009568 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase, and materials and methods for identification of inhibitors thereof |
| 01/15/2004 | US20040009555 Comprises nucleotide sequences coding gum arabic for use in food processing and cosmetics |
| 01/15/2004 | US20040009554 QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 01/15/2004 | US20040009550 Export and modification of (poly)peptides in the lantibiotic way |
| 01/15/2004 | US20040009548 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 01/15/2004 | US20040009547 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 01/15/2004 | US20040009531 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 01/15/2004 | US20040009491 Diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to plasma membrane associated polynucleotides, antigens, and antibodies |
| 01/15/2004 | US20040009488 Nucleic acids, proteins, and antibodies |
| 01/15/2004 | US20040009469 Polypeptides and polynucleotides useful in methods of inducing immune response against flaviviruses, including dengue viruses |
| 01/15/2004 | US20040009187 Rotavirus subunit vaccine |
| 01/15/2004 | US20040009167 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 01/15/2004 | US20040009165 Lysosomal enzymes and lysosomal enzyme activators |
| 01/15/2004 | US20040009164 PSP94 diagnostic reagents and assays |
| 01/15/2004 | CA2491690A1 Plastid genetic engineering via somatic embryogenesis |
| 01/15/2004 | CA2491508A1 Hcv fusion proteins with modified ns3 domains |
| 01/15/2004 | CA2491463A1 Milk-coagulating enzyme originating in bacterium and process for producing cheese using the same |
| 01/15/2004 | CA2491056A1 Benzoate- and anthranilate-inducible promoters |
| 01/15/2004 | CA2490572A1 Pig binding protein from adipocytes |
| 01/14/2004 | EP1380653A1 Method of assaying lupus anticoagulant and assay reagent |
| 01/14/2004 | EP1380651A2 Recombinant fowlpox virus with intact FPV-tk-gene |
| 01/14/2004 | EP1380648A2 Recombinant DNAase B derived from streptococcus pyogenes |
| 01/14/2004 | EP1380646A1 Acetyllysine-recognizing monoclonal antibody and process for producing the same |
| 01/14/2004 | EP1380645A2 Production in bacteria ad yeast of hemoglobin and analogues thereof |
| 01/14/2004 | EP1380594A1 Fibroblast growth factor-10 |
| 01/14/2004 | EP1380593A1 Soluble rage protein |
| 01/14/2004 | EP1380589A1 Protein purification method |
| 01/14/2004 | EP1380570A1 Process for producing n-formylamino acid and utilization thereof |
| 01/14/2004 | EP1379695A2 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 01/14/2004 | EP1379667A2 Methods and compositions for highly efficient production of heterologous proteins in yeast |
| 01/14/2004 | EP1379657A2 Disease-associated protein |
| 01/14/2004 | EP1379656A2 G-protein coupled receptor molecules and uses thereof |
| 01/14/2004 | EP1379655A2 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |
| 01/14/2004 | EP1379654A2 Intracellular signaling molecules |
| 01/14/2004 | EP1379652A2 Human nucleic acid molecules and polypeptides encoding a human ion channel expressed in spinal cord and brain |
| 01/14/2004 | EP1379651A2 Human genes and gene expression products isolated from human prostate |
| 01/14/2004 | EP1379648A1 Full-length human cdnas encoding potentially secreted proteins |
| 01/14/2004 | EP1379646A2 Engineered chimera of protein fragments and methods of use thereof |
| 01/14/2004 | EP1379641A2 Process for the production and purification of secreted proteins and the production of arrays of proteins |
| 01/14/2004 | EP1379638A2 Implantation serine proteinases |
| 01/14/2004 | EP1379637A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
| 01/14/2004 | EP1379628A2 Kinases and phosphatases sequences, and use thereof |
| 01/14/2004 | EP1379555A2 Modified interferon alpha with reduced immunogenicity |
| 01/14/2004 | EP1379550A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/14/2004 | EP1379277A2 Polyclonal populations of bispecific molecules and methods of production and uses thereof |
| 01/14/2004 | EP1379275A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 01/14/2004 | EP1379272A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/14/2004 | EP1379266A2 Modified annexin proteins and methods for preventing thrombosis |
| 01/14/2004 | EP1379125A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 01/14/2004 | EP0975761B1 Recombinant human beta interferon with enhanced solubility |
| 01/14/2004 | EP0832229B1 Cd40l mutein |
| 01/14/2004 | EP0690991B2 Novel anticoagulant cofactor activity |
| 01/14/2004 | CN1468310A Method for constructing cell strain of expression mutation type human tissue plasmin activator and preparation method of expressing protein |
| 01/14/2004 | CN1468309A Anti-il-12 antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468308A Anti-tnf antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468307A Anti-dual integrin antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468306A Schizophrenia related gene and protein |
| 01/14/2004 | CN1468304A Method of producing functional protein domains |
| 01/14/2004 | CN1468303A Factor vii glycoforms |
| 01/14/2004 | CN1468257A Trichosanthin mutant |
| 01/14/2004 | CN1467296A Feeding spore-forming bacillus microbial preparation-glycopeptide and method for making the same |
| 01/14/2004 | CN1134539C Thrombopoietin |
| 01/14/2004 | CN1134452C Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 01/14/2004 | CN1134266C Methods for inducing T cell tolerance to tissue or organ graft |
| 01/13/2004 | US6677443 Isolated nucleic acid encoding lepidopteran octopamine/ tyramine transporter having sodium-dependent transport activity which has affinity for dopamine and which is inhibited by octopamine and tyramine |
| 01/13/2004 | US6677436 Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody |
| 01/13/2004 | US6677433 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins |
| 01/13/2004 | US6677432 Osteogenic protein-1 mutant having at least one amino acid residue substitution, and having improved in vitro refolding properties in ph range of about 6.0-9.0 |
| 01/13/2004 | US6677428 Cdna with nucleotide sequence 1 and protein with amino acid sequence 2 |
| 01/13/2004 | US6677301 Epithelial cell proliferation stimulants; wound healing agents |
| 01/13/2004 | US6677148 Pesticidal proteins |
| 01/13/2004 | US6677138 Production of a multimeric protein by cell fusion method |
| 01/13/2004 | US6677136 Glucagon antagonist domain, preferably having very little or no glucagon agonist activity, yeast-based screening phage display, rna- peptide screening, etc. attached to a vehicle, e.g., an fc domain, peg or dextran |
| 01/13/2004 | US6677127 Nucleic acid respiratory syncytial virus vaccines |
| 01/13/2004 | US6677126 Antibody for human translational regulator |
| 01/13/2004 | US6677124 Monoclonal antibody recognizing C-terminus of hBNP |
| 01/13/2004 | US6676945 Induction immunology response |
| 01/13/2004 | US6676941 For inhibiting angiogenesis and induce tumor regression; cancer therapy |
| 01/13/2004 | US6676938 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 01/13/2004 | US6676924 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
| 01/13/2004 | CA2112811C Continuous cell line and vaccine against avian coccidia |
| 01/13/2004 | CA2000498C Osteogenic factors |
| 01/08/2004 | WO2004003511A2 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 01/08/2004 | WO2004003217A1 Glutathione production |
| 01/08/2004 | WO2004003207A1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 01/08/2004 | WO2004003205A1 Hansenula polymorpha mutant strains with defect in outer chain biosynthesis and the production of recombinant glycoproteins using the same strains |
| 01/08/2004 | WO2004003204A1 Hansenula polymorpha yapsin deficient mutant strain and process for the preparation of recombinant proteins using the same |
| 01/08/2004 | WO2004003202A1 Modified par receptors, their preparation and their uses for selecting compounds which modulate par activity |
| 01/08/2004 | WO2004003196A1 HUMAN IgM ANTIBODY LYSING ACTIVATED LYMPHOCYTES UNDER MEDIATION BY HOMOLOGOUS COMPLEMENT |
| 01/08/2004 | WO2004003195A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 01/08/2004 | WO2004003166A2 Antibodies and uses thereof |
| 01/08/2004 | WO2004003151A2 Protein production methods and modified cells for use therein |
| 01/08/2004 | WO2004003012A2 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 01/08/2004 | WO2004002424A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2004002417A2 Mammalian ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2004002223A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/08/2004 | WO2003085093A3 Antibodies that specifically bind to gmad |
| 01/08/2004 | WO2003078614A3 Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants |